We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Talaris Therapeutics Inc | NASDAQ:TALS | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 2.72 | 2.63 | 2.78 | 0 | 01:00:00 |
From May 2023 to May 2024
By Ben Glickman
Shift Technologies will file for bankruptcy protection as it winds down operations. The company said it has already shuttered its two California locations and stopped operating its website. Shares fall 84% to 30 cents after-hours.
Talaris Therapeutics declared a special dividend conditional on the completion of its merger with Tourmaline Bio. Talaris, which inked a deal with Tourmaline in June, said the cash payout was expected to be $1.51. Talaris shares climb 6.3% to $2.87 after-hours
Lockheed Martin expanded its share buyback program by $6 billion, bringing the total stock purchase program to $13 billion. The aerospace and defense company raised its dividend to $3.15, representing an annualized yield of about 3.1%.
Write to Ben Glickman at ben.glickman@wsj.com
(END) Dow Jones Newswires
October 06, 2023 19:46 ET (23:46 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
1 Year Talaris Therapeutics Chart |
1 Month Talaris Therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
